REV-ERB agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-04. Where a claim depends on a specific study, the study is described rather than over-claimed.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | SR9009; Stenabolic | Nickname is not a chemical name. |
| Typical analytical method | LC-MS/MS | Often with isotope-labeled internal standard. |
| Storage temperature | -20 °C | Desiccated and protected from light. |
| Solution stability | DMSO stock; avoid freeze-thaw | Store at -20 to -80 °C. |
| Regulatory status | Not approved; varies by country | May be restricted as research chemical. |
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
=== Genetics === Type 1 diabetes is partially caused by genetics, and family members of type 1 diabetics have a higher risk of developing the disease themselves. In the general population, the risk of developing type 1 diabetes is around 1 in 250. For someone whose parent has type 1 diabetes, the risk rises to 1–9%. If a sibling has type 1 diabetes, the risk is 6–7%. If someone's identical twin has type 1 diabetes, they have a 30–70% risk of developing it themselves. About half of the disease's heritability is due to variations in three HLA class II genes involved in antigen presentation: HLA-DRB1, HLA-DQA1, and HLA-DQB1. The variation patterns associated with increased risk of type 1 diabetes are called HLA-DR3 and HLA-DR4-HLA-DQ8, and are common in people of European descent. A pattern associated with reduced risk of type 1 diabetes is called HLA-DR15-HLA-DQ6. Large genome-wide association studies have identified dozens of other genes associated with type 1 diabetes risk, mostly genes involved in the immune system.
Mononuclear cells produce proteases and growth factors to digest the extra-cellular scaffold and allow motility and provide space for the new cells. They also produce NO from inducible nitric oxide synthetase (iNOS), which is essential for arteriogenesis. The bulk of new tissue production is carried by the smooth muscles of the media, which transform their phenotype from a contractile into a synthetic and proliferative one. Important roles are played by actin binding proteins like actin-binding Rho-activating protein (ABRA), cofilin, and thymosin beta 4 which determine actin polymerization and maturation. Integrins and connexins are markedly up-regulated. A key role in this concerted action, which leads to a 2-to-20 fold increase in vascular diameter, depending on species size (mouse versus human), are the transcription factors AP-1, egr-1, carp, ets, by the Rho pathway and by the mitogen activated kinases ERK-1 and -2. In spite of the enormous increase in tissue mass (up to 50-fold), the degree of functional restoration of blood flow capacity is incomplete and ends at 30% of maximal coronary conductance and 40% in the vascular periphery. The process of arteriogenesis can be drastically stimulated by increases in FSS (arterio-venous fistulas) and can be completely blocked by inhibition of NO production, by pharmacological blockade of VEGF-A, and by the inhibition of the Rho-pathway.
carbamazepine, phenytoin gastric acid suppressants: antacids, antimuscarinics, histamine H2 blockers, proton pump inhibitors sucralfate rifampin, rifabutin, isoniazid efavirenz, nevirapine Ritonavir (an antiretrovial medication), is known for increasing the activity of ketoconazole. So it is recommended to reduce dosage. There is also a list of drugs which significantly decrease systemic exposure to the ketoconazole and drugs whose systemic exposure is increased by the ketoconazole.
=== Differentiation from pituitary pars intermedia dysfunction === EMS shares similarities to pituitary pars intermedia dysfunction (also known as equine Cushing's disease), which also causes regional adiposity, laminitis, and sometimes insulin resistance. Treatment and management differ between the conditions, making it important to distinguish between the two. However, both diseases may occur simultaneously; horses with EMS may develop PPID.
Sources: en.wikipedia.org
=== Pseudohyperkalemia === Pseudohyperkalemia occurs when the measured potassium level is falsely elevated. Mechanical trauma during blood drawing can cause potassium leakage out of the red blood cells due to haemolysis of the blood sample. Fist clenching during the blood draw can cause a rise in potassium levels in the venous blood as it is sampled; this difference may be as much as 1 mmol/L. Differences of this order of magnitude cause problems (false positive results for clinically-important hyperkalemia) for patients with low glomerular filtration rate (GFR; a measure of kidney function), type IV renal tubular acidosis (RTA), or on evidence-based medication for cardio-renal risk (RASi, MRAs). The practice, widespread in laboratories in North America, should be discontinued. Prolonged storage of blood samples or agitation in transit is also associated with red cell lysis that can increase serum potassium levels. Hyperkalemia may become apparent when a person's platelet concentration is more than 500,000/microL in a clotted blood sample (serum blood sample). Potassium leaks out of platelets after clotting has occurred. A high white cell count (greater than 120,000/microL) in people with chronic lymphocytic leukemia increases the fragility of red blood cells, thus causing pseudohyperkalemia during blood processing. This problem can be avoided by processing serum samples, because clot formation protects the cells from haemolysis during processing.
Three enzymes present in different organisms and tissues are known to catalyse the oxidation of the pyrrole ring in tryptophan, giving the N-formyl deriative which is subsequently hydrolysed to kynurenine. These are tryptophan dioxygenase, indoleamine 2,3-dioxygenase and indoleamine 2,3-dioxygenase 2.
== Carcinoma in situ (230–234) == 230 Carcinoma in situ of digestive organs 231 Carcinoma in situ of respiratory system 232 Carcinoma in situ of skin 233 Carcinoma in situ of breast and genitourinary system 234 Carcinoma in situ of other and unspecified sites
Abbreviations are used very frequently in medicine, despite being widely discouraged by the Institute of Safe Medicine Practices and other organizations concerned about patient safety. Abbreviations are especially discouraged when healthcare providers are communicating with patients and when there is a possibility of confusion between similar abbreviations. Some facilities maintain a list of acceptable abbreviations. Abbreviations are sometimes specific to a facility, which means that newer staff may be unfamiliar with them; this becomes a potential source of preventable medical errors. The Joint Commission and other organizations maintain lists of certain medical abbreviations that should be avoided to prevent mistakes, according to best practices (and in some cases regulatory requirements); these are flagged in the list of abbreviations used in medical prescriptions.
During the night of 21 February, local sources in Afghanistan reported airstrikes in parts of Nangarhar, Paktika, and Khost provinces. In Nangarhar, strikes were reported in the Bihsud and Khogyani districts, while in Paktika, strikes were reported in the Barmal and Urgun districts. Local sources reported that the airstrikes in Nangarhar's Bihsud district struck a civilian home, trapping 23 people beneath the rubble. Pakistan's Ministry of Information and Broadcasting (MolB) stated that the Pakistani military conducted "intelligence-based selective targeting" of seven terrorist camps and hideouts along the Afghanistan-Pakistan border region. The Taliban claimed that the targets included civilian homes and a religious seminary. In a late-night press release, Pakistani officials confirmed that the Pakistan Air Force (PAF), under the command of Air Chief Marshal Zaheer Ahmad Babar, had carried out airstrikes in Afghanistan. Officials said the strikes were selective and intelligence-based, and targeted seven militant camps and hideouts linked to the Tehrik-i-Taliban Pakistan (TTP) and the Islamic State – Khorasan Province (ISIS–K) near the Afghanistan-Pakistan border. Pakistani officials added that the strikes were conducted as retaliation for recent terror attacks in Islamabad, Bajaur, and Bannu.
Sources: en.wikipedia.org
== History == The word esophagus (British English: oesophagus), comes from the Greek: οἰσοφάγος (oisophagos) meaning gullet. It derives from two roots (eosin) to carry and (phagos) to eat. The use of the word esophagus, has been documented in anatomical literature since at least the time of Hippocrates, who noted that "the oesophagus ... receives the greatest amount of what we consume." Its existence in other animals and its relationship with the stomach was documented by the Roman naturalist Pliny the Elder (AD23–AD79), and the peristaltic contractions of the esophagus have been documented since at least the time of Galen. The first attempt at surgery on the esophagus focused in the neck, and was conducted in dogs by Theodore Billroth in 1871. In 1877 Czerny carried out surgery in people. By 1908, an operation had been performed by Voeckler to remove the esophagus, and in 1933 the first surgical removal of parts of the lower esophagus, (to control esophageal cancer), had been conducted. The Nissen fundoplication, in which the stomach is wrapped around the lower esophageal sphincter to stimulate its function and control reflux, was first conducted by Rudolph Nissen in 1955.
== Limitation == Tandem mass spectrometry cannot be applied for single-cell analyses as it is insensitive to analyze such small amounts of a cell. These limitations are primarily due to a combination of inefficient ion production and ion losses within the instruments due to chemical noise sources of solvents.
As part of the agreement, checkpoints of the General Security Forces will be deployed outside the administrative borders of the district, in order to prevent the infiltration of armed groups and stop the conflicts. Entry to villages on the border will be prohibited for 48 hours, to allow the deployment of forces and prevent surprise attacks. Bedouin tribesmen who remain within the district will be allowed to leave under secure escort and without interference, while humanitarian crossings will be opened in emergencies through Busra al-Harir and Busra al-Sham. The spiritual leadership called on all local groups not to leave the district's borders and to refrain from provocations, and made it clear that any party that violates the agreement will be held responsible for the collapse of the understandings. A call was also made to the residents of the governorate to act responsibly and in coordination in order to bring an end to the crisis that has affected them. The newspaper Al-Modon reported on 14 August 2026, that negotiations are underway between the Syrian Transitional Government and Hikmat al-Hijri to reach an agreement similar to the one signed between the Syrian Transitional Government and the Syrian Democratic Forces on 10 March 2026. On 20 August, Arabi Post reported that progress has been made in communications between the Syrian government and the National Guard, with the aim of restoring the functioning of government institutions.
== Draw station == A phlebotomy draw station is a place where blood is drawn from patients for laboratory testing, transfusions, donations, or research purposes. The blood is typically drawn via venipuncture or a finger stick by a healthcare professional such as a phlebotomist, nurse, or medical assistant. The draw station typically includes a padded chair or a bed for patients prone to fainting during blood draws. Draw stations can be found in various settings, such as hospitals, clinics, blood donation centers, and independent laboratories or as part of patient service centers (PSC).
The product forms as a red sodium salt under basic conditions, while white N-hydroxyphthalimide precipitates in 55% yield as the solution is acidified. N-hydroxyphthalimide is also produced by reacting hydroxylamine hydrochloride with diethyl phthalate in the presence of sodium acetate, or with phthalic anhydride in the presence of sodium carbonate with heating. In the last case, an overall yield of 76% is produced following purification by recrystallization. Microwave irradiation of phthalic anhydride and hydroxylamine hydrochloride in pyridine produces N-hydroxyphthalimide in 81% yield. Even in the absence of a base, phthalic anhydride and hydroxylamine phosphate react to produce N-hydroxyphthalimide in 86% yield when heated to 130 °C.
Sources: en.wikipedia.org
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.
Solid material is usually kept at -20 °C, desiccated, and protected from light. Dimethyl sulfoxide stocks should be stored cold and subjected to minimal freeze-thaw cycles. Aqueous solutions are generally less stable and should be prepared fresh when possible.
Legality depends on the country and the intended use. It is not an approved medicine, and some places restrict or ban sales for human consumption. Buyers should verify local rules and product documentation before procurement.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.